> Back to EJC

2016 editions

  • December 2016
    Joao Incio on mechanisms to explain why obesity promotes cancer.
  • November 2016
    Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer.
  • October 2016
    Ruth Muschel on a new target for treatments for colorectal cancer.
  • September 2016
    Freddie Hamdy on the effectiveness of treatments for prostate cancer.
  • August 2016
    Moshe Oren discusses the effects of the microenvironment on cancer cells.
  • July 2016
    Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer.
  • June 2016
    Key advances in clinical trials.
  • May 2016
    Mark Lemmon on the underlying biochemistry of cancer.
  • April 2016
    Roger Stupp on using alternating electric fields as treatment.
  • March 2016
    Charlotte Vrinten on public perception of deaths from cancer.
  • February 2016
    Guillermo Garcia-Manero on myelodysplastic syndromes (MDS).
  • December 2015/January 2016
    Nazneen Rahman on germline genetic screening in ovarian cancer.

> All 2015 Editions

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – October 2015

Loading EJC News Focus video

Latest EUROCARE analysis shows huge variations in cancer survival across Europe

The latest analysis of EUROCARE data, Europe's largest population-based study on cancer survival, found a steady increase in five-year relative survival over time. However, dramatic differences in survival persist. The lowest rates were among older patients, and those who live in Eastern Europe.

Study coordinator Milena Sant (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) presented the results at the first Presidential Session at the European Cancer Congress (Vienna, Austria; 25 - 29 September 2015). She said that some of the largest variations were seen in cancers of the blood. In chronic myeloid leukaemia (CML), for example, five-year relative survival was 33.4% in Eastern Europe, compared to 51-58% in the rest of Europe.

EUROCARE-5 data comes from 117 cancer registries in 31 countries. Here, Milena Sant discusses its implications with Helen Saul.


Survival of Cancer Patients in Europe, 1999 - 2007: The EUROCARE-5 Study. Eds: P. Minicozzi, R. Otter, M. Primic-Zakelj, S. Francisci, European Journal of Cancer, vol 51, issue 15, October 2015, pp 2099-2266